About
Technology
Issues
FAQ
Links
Official Page
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.